Table 6 Studies evaluating maternal BMI as a determinant of maternal or neonatal PFAS concentrations by PFAS, study design, and findings

Legacy PFAS

 PFOA (C/L)

–

–

–

–

8

[42, 61, 62, 65, 78, 81, 82, 88]

 PFOA (C-S)

1

[89]

2

[91, 93]

9

[66, 67, 72, 74, 83, 86, 87, 92, 94]

 PFOS (C/L)

2

[78, 88]

1

[42]

5

[61, 62, 65, 81, 82]

 PFOS (C-S)

1

[89]

4

[67, 74, 83, 91]

7

[66, 72, 86, 87, 92,93,94]

 PFNA (C/L)

–

–

3

[42, 78, 82]

2

[65, 81]

 PFNA (C-S)

1

[86]

1

[94]

7

[66, 74, 83, 87, 89, 91, 93]

 PFHxS (C/L)

–

–

–

–

8

[42, 61, 62, 65, 78, 81, 82, 88]

 PFHxS (C-S)

2

[66, 89]

2

[74, 87]

5

[83, 86, 91, 93, 94]

Other PFAS

 Et-PFOSA-AcOH (C/L)

1

[78]

–

–

–

–

 Me-PFOSA-AcOH (C/L)

1

[78]

–

–

1

[42]

 NMeFOSAA (C-S)

–

–

–

–

1

[74]

 PFDeA (C/L)

–

–

2

[65, 82]

–

–

 PFDeA (C-S)

1

[86]

1

[93]

2

[74, 87]

 PFDoA (C/L)

–

–

1

[82]

1

[88]

 PFDoA (C-S)

1

[86]

–

–

1

[87]

 PFHpA (C-S)

1

[86]

–

–

–

–

 PFHpS (C/L)

–

–

–

–

1

[65]

 PFHpS (C-S)

–

–

–

–

1

[93]

 PFOSA (C-S)

–

–

–

–

1

[86]

 PFPeA (C-S)

–

–

–

–

1

[74]

 PFTrDA (C/L)

–

–

1

[82]

–

–

 PFTrDA (C-S)

–

–

–

–

1

[87]

 PFUnDA (C/L)

–

–

1

[65]

2

[82, 88]

 PFUnDA (C-S)

–

–

2

[74, 93]

3

[86, 87, 89]

 6:2 Cl-PFESA (C/L)

–

–

1

[88]

–

–

 ΣPFAS (C-S)

–

–

–

–

1

[87]